136 related articles for article (PubMed ID: 2198029)
1. Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis.
Shekhonin BV; Tararak EM; Samokhin GP; Mitkevich OV; Mazurov AV; Vinogradov DV; Vlasik TN; Kalantarov GF; Koteliansky VE
Atherosclerosis; 1990 Jun; 82(3):213-26. PubMed ID: 2198029
[TBL] [Abstract][Full Text] [Related]
2. [Apo B, fibrinogen-fibrin and fibronectin in the intima of the normal human aorta and large arteries and in atherosclerosis].
Shekhonin BV; Tararak EM; Samokhin GP; Vinogradov DV; Kotelianskiĭ VE
Arkh Patol; 1990; 52(4):16-21. PubMed ID: 2201275
[TBL] [Abstract][Full Text] [Related]
3. The localization of tissue factor and apolipoprotein(a) in atherosclerotic lesions of the human aorta and their relation to fibrinogen-fibrin transition.
Ichikawa K; Nakagawa K; Hirano K; Sueishi K
Pathol Res Pract; 1996 Mar; 192(3):224-32. PubMed ID: 8739469
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction.
Shekhonin BV; Guriev SB; Irgashev SB; Koteliansky VE
J Mol Cell Cardiol; 1990 May; 22(5):533-41. PubMed ID: 1696997
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic factors in human aortic intima.
Smith EB; Staples EM
Lancet; 1981 May; 1(8231):1171-4. PubMed ID: 6112525
[TBL] [Abstract][Full Text] [Related]
6. Localization of apolipoprotein E in normal and atherosclerotic human aorta.
Babaev VR; Dergunov AD; Chenchik AA; Tararak EM; Yanushevskaya EV; Trakht IN; Sorg C; Smirnov VN
Atherosclerosis; 1990 Dec; 85(2-3):239-47. PubMed ID: 2102087
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.
Xiao Q; Danton MJ; Witte DP; Kowala MC; Valentine MT; Degen JL
J Clin Invest; 1998 Mar; 101(5):1184-94. PubMed ID: 9486990
[TBL] [Abstract][Full Text] [Related]
8. [Fibronectin and fibrinogen/fibrin at the focus of an experimental myocardial infarct].
Shekhonin BV; Guriev SB; Irgashev ShB; Kotelianskiĭ VE
Arkh Patol; 1989; 51(9):14-20. PubMed ID: 2688595
[TBL] [Abstract][Full Text] [Related]
9. Injury and repair of smaller muscular and elastic arteries. Immunohistochemical demonstration of fibronectin and fibrinogen/fibrin and their degradation products in rabbit femoral and common carotid arteries following a dilatation injury.
Rasmussen LH; Garbarsch C; Chemnitz J; Christensen BC; Lorenzen I
Virchows Arch A Pathol Anat Histopathol; 1989; 415(6):579-85. PubMed ID: 2508316
[TBL] [Abstract][Full Text] [Related]
10. Fate of fibrinogen in human arterial intima.
Smith EB; Keen GA; Grant A; Stirk C
Arteriosclerosis; 1990; 10(2):263-75. PubMed ID: 2317160
[TBL] [Abstract][Full Text] [Related]
11. Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries.
Shekhonin BV; Domogatsky SP; Idelson GL; Koteliansky VE; Rukosuev VS
Atherosclerosis; 1987 Sep; 67(1):9-16. PubMed ID: 3314885
[TBL] [Abstract][Full Text] [Related]
12. Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta.
Orekhov AN; Andreeva ER; Shekhonin BV; Tertov VV; Smirnov VN
Atherosclerosis; 1984 Nov; 53(2):213-9. PubMed ID: 6393995
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin distribution in human aortic intima and atherosclerotic lesions: concentration of soluble and collagenase-releasable fractions.
Smith EB; Ashall C
Biochim Biophys Acta; 1986 Jan; 880(1):10-5. PubMed ID: 3002486
[TBL] [Abstract][Full Text] [Related]
14. [Immuno-morphologic detection of specific APO-B antigenic determinants in normal intima and atherosclerotic plaques in the human aorta].
Shekhonin BV; Tararak EM; Kovaleva EA; Ianushevskaia EV; Trakht IN
Arkh Patol; 1989; 51(2):23-30. PubMed ID: 2469412
[TBL] [Abstract][Full Text] [Related]
15. Role of A alpha chain of fibrinogen in coagulation and platelet interaction investigated with a monoclonal antibody.
Thurlow PJ; Connellan JM; Kenneally DA
Thromb Res; 1987 Aug; 47(4):427-39. PubMed ID: 3310325
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen/fibrin in atherogenesis.
Smith EB; Thompson WD; Crosbie L; Stirk CM
Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
[TBL] [Abstract][Full Text] [Related]
17. Distribution patterns of apolipoproteins A1, A2, and B in the wall of atherosclerotic vessels.
Vollmer E; Brust J; Roessner A; Bosse A; Burwikel F; Kaesberg B; Harrach B; Robenek H; Böcker W
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):79-88. PubMed ID: 1908160
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. I. Relation between fibrin and immobilization of apo B-containing lipoprotein.
Smith EB; Keen GA; Grant A
Atherosclerosis; 1990 Oct; 84(2-3):165-71. PubMed ID: 2149267
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin and atherosclerosis.
Stenman S; von Smitten K; Vaheri A
Acta Med Scand Suppl; 1980; 642():165-70. PubMed ID: 6935942
[TBL] [Abstract][Full Text] [Related]
20. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
Bini A; Fenoglio JJ; Mesa-Tejada R; Kudryk B; Kaplan KL
Arteriosclerosis; 1989; 9(1):109-21. PubMed ID: 2643421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
